2006 Conference Publication Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancerSimerska, P., Moyle, P. M., Olive, C., Sun, H. K., Ho, M. F., Pandy, M. G., Dyer, J. R., Burgess, M. L. and Toth, I. (2006). Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer. GPEN 2006, Lawrence, USA, 25-27 October, 2006. |
2005 Conference Publication Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptidesOlive, C., Hsien, K., Horvath, A., Clair, T., Yarwood, P., Toth, I. and Good, M. F. (2005). Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Oxford, U.K.: Elsevier. doi: 10.1016/j.vaccine.2005.01.041 |
2005 Conference Publication The chemoenzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug deliveryJohnstone, K.D., Dieckelmann, M., Jennings, M.P., Blanchfield, J.T. and Toth, I. (2005). The chemoenzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery. 19th American Peptide Symposium, San Diego, CA, United States, 18-23 June 2005. Hoboken, NJ, United States: John Wiley & Sons . |
2005 Conference Publication A synthetic group A streptococcal vaccine of high purity and broad protective rangeHorvath, Aniko, Olive, Colleen, Good, Michael F. and Toth, Istvan (2005). A synthetic group A streptococcal vaccine of high purity and broad protective range. 3rd International Peptide Symposium/28th European Peptide Symposium, Prague Czech Republic, Sep 05-10, 2004. GENEVA 1: KENES INT. |
2005 Conference Publication The synthesis and immunological activity of a lipid-core peptide (LCP) based Human Papillomavirus (HPV) type-16 vaccineMoyle, Peter M., Olive, Colleen, Sun, Hsien, Good, Michael and Toth, Istvan (2005). The synthesis and immunological activity of a lipid-core peptide (LCP) based Human Papillomavirus (HPV) type-16 vaccine. 3rd International Peptide Symposium and 28th European Peptide Symposium, Prague, Czech Republic, 5-10 September 2004. GENEVA 1: Kenes International. |
2005 Conference Publication Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cellsWimmer, N., Robinson, J. A., Thomson, S. J., Monteith, G. R. and Toth, I. (2005). Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, U.S., 18-23 June, 2005. Hoboken, U.S.: Wiley Interscience. |
2004 Conference Publication Novel vaccine delivery systemsToth, I. (2004). Novel vaccine delivery systems. GPEN 2004, Kyoto, 26-28 May, 2004. |
2004 Conference Publication Liposaccharides in peptide drug deliveryBlanchfield, J. T., Gallagher, O. P., Koda, Y., Alewood, P.F., Lewis, R. J. and Toth, I. (2004). Liposaccharides in peptide drug delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2003. WASHINGTON: AMER CHEMICAL SOC. |
2004 Conference Publication Liposaccharides for drug and vaccine deliveryToth, I., Horvath, A., Karpati, L., Moyle, P., Olive, C. and Good, M. (2004). Liposaccharides for drug and vaccine delivery. 3rd International and 28th European Peptide Symposium, Prague, Czech Republic, 5–10 September 2004. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.618 |
2004 Conference Publication A novel liposaccharide system for the delivery of Endormorphin 1Koda, Y., Blanchfield, J. T., Okada, Y. and Toth, I. (2004). A novel liposaccharide system for the delivery of Endormorphin 1. PSWC 2004, Kyoto, 29 May- 3 June, 2004. |
2004 Conference Publication Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparationLiang, M.T., Davies, N. M. and Toth, I. (2004). Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association. |
2004 Conference Publication Investigation of urotensin-II converting enzyme activity in human cells and bloodKearns, P., Russell, F. D., Toth, I. and Molenaar, P. (2004). Investigation of urotensin-II converting enzyme activity in human cells and blood. 8th Annual Scientific Sessions of the Latin American Section of the International-Society for Heart Research, Brisbane, Qld, Australia, 7th - 11th August, 2004. United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003 |
2004 Conference Publication Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsionsLiang, M. T., Davies, N. M. and Toth, I. (2004). Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions. CTP 2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing Asia. |
2004 Conference Publication Liposaccharide delivery system: application to conotoxin MII and endomorphin IBlanchfield, J. T., Koda, Y., Gallagher, O. P. and Toth, I. (2004). Liposaccharide delivery system: application to conotoxin MII and endomorphin I. PSWC 2004, Kyoto, 29 May - 3 June, 2004. |
2004 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E.P. (2004). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2004. |
2004 Conference Publication Liposaccharide delivery system: Application to Conotoxin MII and Endomorphin 1Blanchfield, J. T., Koda, Y., Gallagher, O. P. and Toth, I. (2004). Liposaccharide delivery system: Application to Conotoxin MII and Endomorphin 1. 20th RACI Organic Chemistry Conference, Cairns, 4-8 July, 2004. |
2003 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 November, 2003. |
2003 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 26th Australian Polymer Symposium, Noosa, Queensland, 13-17 July 2003. Australia: Royal Australian Chemical Institute. |
2003 Conference Publication Vaccine design against streptococcal infectionToth, I, Horvath, A, Olive, C and Good, MF (2003). Vaccine design against streptococcal infection. 18th American Peptide Symposium, Boston Ma, Jul 19-23, 2003. HOBOKEN: JOHN WILEY & SONS INC. |
2003 Conference Publication Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated deliveryMarano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery. 3rd Meeting of the Australasian-Gene-Therapy-Society, Brisbane Australia, Apr 30-May 02, 2003. CHICHESTER: Wiley. |